BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21599584)

  • 1. Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type.
    Ennishi D; Maeda Y; Fujii N; Kondo E; Shinagawa K; Ikeda K; Ichimura K; Yoshino T; Tanimoto M
    Leuk Lymphoma; 2011 Jul; 52(7):1255-61. PubMed ID: 21599584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
    Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
    Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
    Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
    Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
    Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
    Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Philippe Walter L; Couronné L; Jais JP; Nguyen PD; Blaise D; Pigneux A; Socié G; Thieblemont C; Bachy E; Fegueux N; Chevallier P; Mohty M; Yakoub-Agha I; Peffault de Latour R; Jaccard A; Hermine O;
    Am J Hematol; 2021 Jul; 96(7):834-845. PubMed ID: 33864708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extranodal natural killer/T cell lymphoma: we should and we can do more.
    Ying Z; Zhu J
    Chin Clin Oncol; 2015 Mar; 4(1):12. PubMed ID: 25841719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
    Suzuki R
    Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.
    Wang J; Wei L; Ye J; Yang L; Li X; Cong J; Yao N; Cui X; Wu Y; Ding J; Zhang L
    Int J Hematol; 2018 Jan; 107(1):98-104. PubMed ID: 28856590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma.
    Cudillo L; Cerretti R; Picardi A; Mariotti B; De Angelis G; Cantonetti M; Postorino M; Ceresoli E; De Santis G; Nasso D; Pisani F; Scala E; Di Piazza F; Lanti A;
    Ann Hematol; 2018 Jun; 97(6):1041-1048. PubMed ID: 29442161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
    Murashige N; Kami M; Kishi Y; Kim SW; Takeuchi M; Matsue K; Kanda Y; Hirokawa M; Kawabata Y; Matsumura T; Kusumi E; Hirabayashi N; Nagafuji K; Suzuki R; Takeuchi K; Oshimi K
    Br J Haematol; 2005 Aug; 130(4):561-7. PubMed ID: 16098071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma.
    Li M; Gao C; Li H; Wang Z; Cao Y; Huang W; Li X; Wang S; Yu L; Da W
    Med Oncol; 2011 Sep; 28(3):840-5. PubMed ID: 20414818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of early diagnosis on the prognosis of extranodal NK/T-cell lymphoma with massive lung involvement: a case report.
    Yabushita T; Yoshioka S; Furumiya T; Nakamura M; Yamashita D; Imai Y; Ishikawa T
    BMC Pulm Med; 2019 Feb; 19(1):48. PubMed ID: 30791900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.
    Brammer JE; Chihara D; Poon LM; Caimi P; de Lima M; Ledesma C; Rondon G; Ciurea SO; Nieto Y; Fanale M; Dabaja B; Maziarz RT; Champlin RE; Hosing C; Oki Y
    Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e41-e50. PubMed ID: 29277360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.
    Kohrt H; Advani R
    Leuk Lymphoma; 2009 Nov; 50(11):1773-84. PubMed ID: 19883307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study.
    Lee J; Au WY; Park MJ; Suzumiya J; Nakamura S; Kameoka J; Sakai C; Oshimi K; Kwong YL; Liang R; Yiu H; Wong KH; Cheng HC; Ryoo BY; Suh C; Ko YH; Kim K; Lee JW; Kim WS; Suzuki R
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1356-64. PubMed ID: 19041057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.